Literature DB >> 9527150

Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome.

R J Lane1, M C Barrett, D Woodrow, J Moss, R Fletcher, L C Archard.   

Abstract

OBJECTIVES: To examine the proportions of type 1 and type 2 muscle fibres and the degree of muscle fibre atrophy and hypertrophy in patients with chronic fatigue syndrome in relation to lactate responses to exercise, and to determine to what extent any abnormalities found might be due to inactivity.
METHODS: Quadriceps needle muscle biopsies were obtained from 105 patients with chronic fatigue syndrome and the proportions of type 1 and 2 fibres and fibre atrophy and hypertrophy factors were determined from histochemical preparations, using a semiautomated image analysis system. Forty one randomly selected biopsies were also examined by electron microscopy. Lactate responses to exercise were measured in the subanaerobic threshold exercise test (SATET).
RESULTS: Inactivity would be expected to result in a shift to type 2 fibre predominance and fibre atrophy, but type 1 predominance (23%) was more common than type 2 predominance (3%), and fibre atrophy was found in only 10.4% of cases. Patients with increased lactate responses to exercise did have significantly fewer type 1 muscle fibres (p<0.043 males, p<0.0003 females), but there was no evidence that this group was less active than the patients with normal lactate responses. No significant ultrastructural abnormalities were found.
CONCLUSION: Muscle histometry in patients with chronic fatigue syndrome generally did not show the changes expected as a result of inactivity. However, patients with abnormal lactate responses to exercise had a significantly lower proportion of mitochondria rich type 1 muscle fibres.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9527150      PMCID: PMC2169994          DOI: 10.1136/jnnp.64.3.362

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  42 in total

Review 1.  Muscle biochemistry and pathophysiology in postviral fatigue syndrome.

Authors:  R H Edwards; D J Newham; T J Peters
Journal:  Br Med Bull       Date:  1991-10       Impact factor: 4.291

2.  Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome. A 31P nuclear magnetic resonance study.

Authors:  D L Arnold; P J Bore; G K Radda; P Styles; D J Taylor
Journal:  Lancet       Date:  1984-06-23       Impact factor: 79.321

3.  Mitochondrial abnormalities in the postviral fatigue syndrome.

Authors:  W M Behan; I A More; P O Behan
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

4.  The relative isometric strength of type I and type II muscle fibres in the human quadriceps.

Authors:  A Young
Journal:  Clin Physiol       Date:  1984-02

5.  Chronic fatigue syndrome: studies on skeletal muscle.

Authors:  J M Grau; J Casademont; E Pedrol; J Fernández-Solà; F Cardellach; N Barros; A Urbano-Márquez
Journal:  Clin Neuropathol       Date:  1992 Nov-Dec       Impact factor: 1.368

6.  Single fibre EMG studies in chronic fatigue syndrome: a reappraisal.

Authors:  L Roberts; E Byrne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

7.  Energy metabolism in human slow and fast twitch fibres during prolonged cycle exercise.

Authors:  M Ball-Burnett; H J Green; M E Houston
Journal:  J Physiol       Date:  1991-06       Impact factor: 5.182

8.  Type 2 fiber predominance in muscle cramp and exertional myalgia.

Authors:  N Telerman-Toppet; M Bacq; P Khoubesserian; C Coërs
Journal:  Muscle Nerve       Date:  1985-09       Impact factor: 3.217

9.  Skeletal muscle metabolism in the chronic fatigue syndrome. In vivo assessment by 31P nuclear magnetic resonance spectroscopy.

Authors:  R Wong; G Lopaschuk; G Zhu; D Walker; D Catellier; D Burton; K Teo; R Collins-Nakai; T Montague
Journal:  Chest       Date:  1992-12       Impact factor: 9.410

10.  Muscle performance, voluntary activation, twitch properties and perceived effort in normal subjects and patients with the chronic fatigue syndrome.

Authors:  A R Lloyd; S C Gandevia; J P Hales
Journal:  Brain       Date:  1991-02       Impact factor: 13.501

View more
  17 in total

Review 1.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

2.  Cardiorespiratory and neuromuscular deconditioning in fatigued and non-fatigued breast cancer survivors.

Authors:  Sarah E Neil; Riggs J Klika; S Jayne Garland; Donald C McKenzie; Kristin L Campbell
Journal:  Support Care Cancer       Date:  2012-09-28       Impact factor: 3.603

Review 3.  Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms.

Authors:  Frank Nm Twisk
Journal:  World J Methodol       Date:  2015-06-26

4.  Potential role of pioglitazone, caffeic acid and their combination against fatigue syndrome-induced behavioural, biochemical and mitochondrial alterations in mice.

Authors:  Anil Kumar; Aditi Vashist; Puneet Kumar
Journal:  Inflammopharmacology       Date:  2010-07-03       Impact factor: 4.473

5.  Strength and physiological response to exercise in patients with chronic fatigue syndrome.

Authors:  K Y Fulcher; P D White
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

Review 6.  Chronic fatigue syndrome: an update.

Authors:  R J Shephard
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

7.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

Review 8.  Specific correlations between muscle oxidative stress and chronic fatigue syndrome: a working hypothesis.

Authors:  Stefania Fulle; Tiziana Pietrangelo; Rosa Mancinelli; Raoul Saggini; Giorgio Fanò
Journal:  J Muscle Res Cell Motil       Date:  2008-02-15       Impact factor: 2.698

9.  Enterovirus related metabolic myopathy: a postviral fatigue syndrome.

Authors:  R J M Lane; B A Soteriou; H Zhang; L C Archard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

Review 10.  Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Authors:  Gerwyn Morris; George Anderson; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-06-13       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.